|
|
||||||||
Department of Pharmacology, Therapeutics, and Toxicology and Sir Geraint Evans Wales Heart Research Institute, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom
Left ventricular hypertrophy (LVH) is
a cardiovascular risk factor. A possible role for endothelial
dysfunction in this condition was investigated in a Dunkin-Hartley
guinea pig aortic-banded pressure overload-induced model of LVH. Aortic
banding produced significant elevation of fore- and hindlimb blood
pressure (BP), heart-to-body weight ratios, plasma angiotensin II (ANG
II), endothelin-1 (ET-1), tumor necrosis factor-
(TNF-
) levels,
and coronary microvascular endothelial cell (CMEC) NAD(P)H-dependent
superoxide (O
levels, and O
ace inhibitors; antioxidant; left ventricular hypertrophy; endothelial function; oxygen-derived free radicals
This article has been cited by other articles:
![]() |
A. Csiszar, K. E. Smith, A. Koller, G. Kaley, J. G. Edwards, and Z. Ungvari Regulation of Bone Morphogenetic Protein-2 Expression in Endothelial Cells: Role of Nuclear Factor-{kappa}B Activation by Tumor Necrosis Factor-{alpha}, H2O2, and High Intravascular Pressure Circulation, May 10, 2005; 111(18): 2364 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Lang Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality? Heart, April 1, 2002; 87(4): 316 - 317. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |